Valeant Shares Have Record Day as Investors Get Relief, for NowBy
Shares rise a record 25 percent, bonds surge as well
Drugmaker maintains guidance, promises strategic overhaul
Valeant Pharmaceuticals International Inc. shareholders are finally giving the drugmaker a chance, at least until next quarter.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.